Zacks Investment Research upgraded shares of FUJIFILM (OTCMKTS:FUJIY) from a sell rating to a hold rating in a research note published on Tuesday.
According to Zacks, “FUJIFILM has outperformed the industry in the past year. The company has positive record of earnings surprises in recent quarters. The company is benefiting from strong growth in medical systems and electronic materials businesses. We believe the expanding product portfolio will boost company’s share in the healthcare market, consequently driving top-line growth. The company has also forged partnerships with the likes of Takeda Pharmaceutical to solidify its position in the healthcare market. However, the company’s choppy Document Solutions business remains a major concern. Moreover, restructuring expenses might weigh over near-term margins as well. Additionally, expected proxy fight between FUJIFILM and activist investors over the Xerox acquisition is expected to hurt share price at least in the near term.”
Shares of OTCMKTS FUJIY opened at $39.47 on Tuesday. The company has a market cap of $17,561.57, a price-to-earnings ratio of 14.65, a PEG ratio of 2.45 and a beta of 0.34. FUJIFILM has a 52-week low of $35.25 and a 52-week high of $43.44. The company has a debt-to-equity ratio of 0.18, a quick ratio of 2.56 and a current ratio of 3.28.
FUJIFILM (OTCMKTS:FUJIY) last posted its earnings results on Wednesday, January 31st. The technology company reported $1.08 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.67 by $0.41. The company had revenue of $5.51 billion during the quarter, compared to analyst estimates of $5.60 billion. FUJIFILM had a return on equity of 7.44% and a net margin of 7.24%. equities research analysts predict that FUJIFILM will post 2.88 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “FUJIFILM (FUJIY) Upgraded by Zacks Investment Research to Hold” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The legal version of this article can be read at https://www.dispatchtribunal.com/2018/04/07/fujifilm-fujiy-upgraded-by-zacks-investment-research-to-hold.html.
FUJIFILM Holdings Corporation is engaged in the development, production, sales and service of imaging solutions, information solutions and document solutions. The Company’s segments include Imaging Solutions, Information Solutions, Document Solutions and, Corporate expenses and eliminations. The Imaging Solutions segment consists of photo imaging, and optical device and electronic imaging products.
Get a free copy of the Zacks research report on FUJIFILM (FUJIY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for FUJIFILM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FUJIFILM and related companies with MarketBeat.com's FREE daily email newsletter.